Vertex Q4 Earnings On Deck: Will This Biotech Heavyweight Keep Its Edge?
Vertex Pharmaceuticals (VRTX) reports Q4 earnings today. Investors are eager for updates on new drug launches and growth ...
Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Intrinsic Value Is Potentially 50% Above Its Share Price
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...
US Stocks To Open On A Positive Note After A String Of Bad Mondays: Recent Dip Has 'Reached Its Low Point,' Says Technical Analyst
U.S. stock futures rose on Monday after Friday’s sharp fall as investors digested the tariff updates and earnings reports.
These Stocks Are Moving the Most Today: Nucor, U.S. Steel, Meta, Tesla, BP, McDonald’s, and More
Stock futures were rising Monday, kicking off a week filled with threatened tariffs from President Donald Trump and key ...
Top Wall Street Forecasters Revamp Vertex Pharmaceuticals Price Expectations Ahead Of Q4 Earnings
Analysts expect the Boston, Massachusetts-based company to report quarterly earnings at $4.02 per share, down from $4.20 per share in the year-ago period. Vertex Pharmaceuticals projects quarterly ...
The FDA just approved a new painkiller. Is it too good to be true?
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
Wall Street week ahead: Investors’ focus on Trump’s reciprocal tariffs, inflation data, Jerome Powell’s testimony
The focus of Wall Street investors in the week ahead will be primarily on expected reciprocal trade tariffs by US President ...